{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T14:23:38Z","timestamp":1772893418369,"version":"3.50.1"},"reference-count":15,"publisher":"Hindawi Limited","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1811,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1111\/j.1600-0404.2010.01426.x","type":"journal-article","created":{"date-parts":[[2010,9,16]],"date-time":"2010-09-16T13:28:39Z","timestamp":1284643719000},"page":"430-433","source":"Crossref","is-referenced-by-count":35,"title":["Delivery of healthy babies after natalizumab use for multiple sclerosis: a report of two cases"],"prefix":"10.1155","volume":"123","author":[{"given":"I. A.","family":"Hoevenaren","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. C.","family":"de Vries","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. J. P.","family":"Rijnders","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F. K.","family":"Lotgering","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"98","published-online":{"date-parts":[[2010,9,16]]},"reference":[{"key":"10.1111\/j.1600-0404.2010.01426.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/S0140-6736(08)61620-7","article-title":"Multiple sclerosis","volume":"372","author":"Compston","year":"2008","journal-title":"Lancet"},{"key":"10.1111\/j.1600-0404.2010.01426.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ejogrb.2003.10.020","article-title":"Multiple sclerosis: management issues during pregnancy","volume":"115","author":"Ferrero","year":"2004","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1111\/j.1600-0404.2010.01426.x-BIB3|cit3","unstructured":"E uropean M edicines A gency Summary of product characteristics Tysabri http:\/\/www.emea.europa.eu\/humandocs\/PDFs\/EPAR\/tysabri\/emea-combined-h603en.pdf"},{"key":"10.1111\/j.1600-0404.2010.01426.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.drudis.2007.05.001","article-title":"Alpha4-integrin antagonism - an effective approach for the treatment of inflammatory diseases?","volume":"12","author":"Davenport","year":"2007","journal-title":"Drug Discov Today"},{"key":"10.1111\/j.1600-0404.2010.01426.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1046\/j.1525-1373.2000.22348.x","article-title":"The role of integrins in reproduction","volume":"223","author":"Bowen","year":"2000","journal-title":"Proc Soc Exp Biol Med"},{"issue":"s449","key":"10.1111\/j.1600-0404.2010.01426.x-BIB6|cit6","first-page":"1150","article-title":"Natalizumab use during pregnancy","volume":"103","author":"Mahadevan","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1600-0404.2010.01426.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0010-7824(93)90088-O","article-title":"Oral contraceptives and reproductive factors in multiple sclerosis incidence","volume":"47","author":"Villard-Mackintosh","year":"1993","journal-title":"Contraception"},{"key":"10.1111\/j.1600-0404.2010.01426.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1212\/01.wnl.0000188898.02018.95","article-title":"Pregnancy, delivery, and birth outcome in women with multiple sclerosis","volume":"65","author":"Dahl","year":"2005","journal-title":"Neurology"},{"key":"10.1111\/j.1600-0404.2010.01426.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s00415-008-0757-2","article-title":"Pregnancy, delivery and birth outcome in different stages of maternal multiple sclerosis","volume":"255","author":"Dahl","year":"2008","journal-title":"J Neurol"},{"key":"10.1111\/j.1600-0404.2010.01426.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1177\/1352458508101937","article-title":"Does multiple sclerosis increase risk of adverse pregnancy outcomes? A population-based study","volume":"15","author":"Chen","year":"2009","journal-title":"Mult Scler"},{"key":"10.1111\/j.1600-0404.2010.01426.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1600-0404.2007.00978.x","article-title":"Reproductive counseling, treatment and course of pregnancy in 73 German MS patients","volume":"118","author":"Hellwig","year":"2008","journal-title":"Acta Neurol Scand"},{"key":"10.1111\/j.1600-0404.2010.01426.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.1093\/oxfordjournals.humrep.a135906","article-title":"Materno-fetal immunoglobulin transfer and passive immunity during the first trimester of human pregnancy","volume":"10","author":"Jauniaux","year":"1995","journal-title":"Hum Reprod"},{"key":"10.1111\/j.1600-0404.2010.01426.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1600-0897.1996.tb00172.x","article-title":"Evolution of maternofetal transport of immunoglobulins during human pregnancy","volume":"36","author":"Malek","year":"1996","journal-title":"Am J Reprod Immunol"},{"key":"10.1111\/j.1600-0404.2010.01426.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1056\/NEJMoa044397","article-title":"A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis","volume":"354","author":"Polman","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-0404.2010.01426.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/bdrb.20193","article-title":"Postnatal development in cynomolgus monkeys following prenatal exposure to natalizumab, an \u03b14 integrin inhibitor","volume":"86","author":"Wehner","year":"2009","journal-title":"Birth Defects Res B Dev Reprod Toxicol"}],"container-title":["Acta Neurologica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0404.2010.01426.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1600-0404.2010.01426.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T12:49:07Z","timestamp":1671540547000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0404.2010.01426.x"}},"subtitle":["Delivery of healthy babies after natalizumab for multiple sclerosis"],"short-title":[],"issued":{"date-parts":[[2010,9,16]]},"references-count":15,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,6]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1600-0404.2010.01426.x","relation":{},"ISSN":["0001-6314"],"issn-type":[{"value":"0001-6314","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9,16]]}}}